Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Related Studies

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003944. Last updated on October 12, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Fallopian Tube Cancer
		Ovarian Cancer
		Peritoneal Cavity Cancer

2	Additional conditions recognized in this trial
		Fallopian Tube Neoplasms
		Ovarian Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Fallopian Tube Diseases
		Genital Diseases, Female
		Genital Neoplasms, Female
		Gonadal Disorders
		Neoplasms
		Neoplasms by Site
		Ovarian Diseases
		Urogenital Neoplasms

4	Interventions listed in this trial
		carboplatin
		cyclophosphamide
		filgrastim
		paclitaxel
		topotecan hydrochloride

5	Additional drug interventions recognized in this trial
		Topotecan

6	More general drug interventions related to this trial
		Alkylating Agents
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Phytogenic
		Antirheumatic Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		Fox Chase Cancer Center
		National Cancer Institute (NCI)